Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Financial Ratios

NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Financial Ratios History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs) 77.5639.199.3224.1625.32
   CEPS(Rs) 87.9948.1717.1330.6530.65
   DPS(Rs) 9.505.504.505.256.75
   Book NAV/Share(Rs) 326.99267.06233.44224.88206.04
   Tax Rate(%) 17.0417.0115.9223.6719.45
Margin Ratios
   Core EBITDA Margin(%) 40.4331.6411.8928.9728.31
   EBIT Margin(%) 39.0830.429.9228.4528.68
   Pre Tax Margin(%) 38.6329.919.1227.8127.63
   PAT Margin (%) 32.0524.837.6721.2322.26
   Cash Profit Margin (%) 36.3630.5114.1026.8427.11
Performance Ratios
   ROA(%) 22.1313.293.439.4310.30
   ROE(%) 25.8815.664.0611.2712.71
   ROCE(%) 30.0818.064.8613.9914.82
   Asset Turnover(x) 0.690.540.450.440.46
   Sales/Fixed Asset(x) 1.240.890.760.861.07
   Working Capital/Sales(x) 1.421.241.251.151.25
Efficiency Ratios
   Fixed Capital/Sales(x) 0.811.131.321.160.93
   Receivable days 86.1693.5385.1084.4493.77
   Inventory Days 60.8195.32128.47118.7796.38
   Payable days 136.43133.18106.38151.52243.26
Valuation Parameters
   PER(x) 12.2714.3881.3034.1619.99
   PCE(x) 10.8111.7044.2126.9216.51
   Price/Book(x) 2.912.113.243.672.46
   Yield(%) 1.000.980.590.641.33
   EV/Net Sales(x) 4.113.667.217.334.94
   EV/Core EBITDA(x) 8.759.5238.6721.1913.71
   EV/EBIT(x) 9.7111.3063.7525.3716.03
   EV/CE(x) 2.651.973.003.432.31
   M Cap / Sales 4.263.807.117.344.81
Growth Ratio
   Net Sales Growth(%) 47.7239.20-5.237.16-8.57
   Core EBITDA Growth(%) 80.69186.95-48.932.87-25.41
   EBIT Growth(%) 93.14298.54-62.910.46-30.07
   PAT Growth(%) 94.09320.76-61.57-3.43-28.69
   EPS Growth(%) 97.88320.76-61.44-4.58-28.30
Financial Stability Ratios
   Total Debt/Equity(x) 0.060.030.090.060.08
   Current Ratio(x) 4.144.393.504.463.39
   Quick Ratio(x) 3.473.352.493.042.63
   Interest Cover(x) 88.1660.4412.4244.5827.45
   Total Debt/Mcap(x) 0.020.020.030.020.03

Compare Financial Ratios of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,628.3 Cr -6.6% 0.8% -22.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,614.0 Cr -2.5% -4.7% 11.9% Stock Analytics
DIVIS LABORATORIES ₹173,533.0 Cr -2.7% -0.7% 50.4% Stock Analytics
CIPLA ₹121,439.0 Cr -1.2% 0.8% -0.9% Stock Analytics
DR REDDYS LABORATORIES ₹110,076.0 Cr -2.3% 8.2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,066.0 Cr 1.4% -1.5% 13.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-6.6%

0.8%

-22.8%

SENSEX

-1%

-0.9%

6.7%


You may also like the below Video Courses